By Azumio
Report updated May 19, 2026
Glucose Buddy Diabetes Tracker
For individuals managing diabetes who require consistent blood glucose tracking, carb logging, and professional health guidance.
Glucose Buddy Diabetes Tracker is a struggling medical app that is available. With a 3.9/5 rating from 39.1K reviews, it struggles with user retention. Users particularly appreciate comprehensive health tracking features allow users to monitor glucose and blood pressure effectively, though persistent application crashes and loading failures prevent access to critical health data remains a common concern.
What is Glucose Buddy Diabetes Tracker?
Glucose Buddy is a diabetes management app for iOS and Android that tracks blood glucose, A1C, and medication.
Users hire the app to centralize chronic health data for physician reporting and long-term trend analysis.
Current Momentum
v5.442 · 3w ago
Maintenance- Shipped refreshed design interface.
- Deployed performance upgrades and bug fixes.
Active Nemesis
mySugr - Diabetes Tracker Log
By mySugr
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Direct data sync with Agamatrix Jazz Wireless 2 and Dexcom devices
Calculates long-term blood sugar trends based on logged entries
One-on-one support from certified diabetes educators via messaging
How much does it cost?
- Free tier with ad support
- Premium tier starting at $19/month
Subscription model anchored at $19/month, utilizing a freemium funnel to upsell coaching and advanced analytics.
Who Built It?
Azumio
Providing comprehensive diabetes management through integrated data logging, hardware connectivity, and professional coaching.
Portfolio
4
Apps
Who is Azumio?
Azumio occupies a specialized niche in the mHealth market by evolving from simple data logging into a hybrid platform that integrates hardware connectivity with human-led professional coaching. Their primary moat is a decade of brand equity and established integrations with smart meters, which differentiates them from newer, software-only competitors. However, the publisher faces a strategic challenge in maintaining technical stability as they transition legacy users toward a high-ticket subscription model.
Who is Azumio for?
- Individuals living with diabetes who require both digital tracking tools
- Professional human support to manage their condition effectively
Portfolio momentum
Released 2 updates across 2 apps in the last 6 months, maintaining a 100% active portfolio.
What other apps does Azumio make?
Glucose Buddy+ for Diabetes
Instant Fitness: Workout Trainer
Argus: Pedometer Step Tracker
What do users think recently?
High confidence · Latest 87 of 101 total reviews analyzed · Based on 101 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a upset sentiment. Users appreciate comprehensive health tracking features allow users to monitor glucose and blood pressure effectively, but report persistent application crashes and loading failures prevent access to critical health data and aggressive subscription prompts and paywalls frustrate users attempting to access basic functionality.
What Users Love
What Frustrates Users
What Users Want
What is the competitive landscape for Glucose Buddy Diabetes Tracker?
How's The Medical Market?
How does it evolve in the Medical market?
Glucose Buddy ranks #48 Grossing in the US Medical category, but the 2.25★ Android rating against a 4.8★ iOS rating indicates a fragmented user experience. The grossing rank significantly trails the app's long-standing market presence, signaling that monetization friction is outpacing user value.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇰🇪 Kenya | Medical | iOSGrossing | #17 | ▲2 |
| 🇳🇬 Nigeria | Medical | iOSGrossing | #50 | ▼4 |
The rivals identified
The Nemesis
mySugr - Diabetes Tracker Log
★4.5 (134.1K)mySugr GmbH
⚡With over 134,000 reviews and a high-velocity release cadence, mySugr is the dominant direct competitor in the diabetes logging space.
Head to Head
To compete, the target app must pivot from a passive logging tool to an active, gamified health companion that provides actionable clinical insights rather than just historical data.
What sets Glucose Buddy Diabetes Tracker apart
Long-standing market presence of 15 years builds significant trust for legacy diabetes management users
Simplified, all-in-one dashboard design reduces the cognitive load for patients tracking multiple health metrics
What's mySugr - Diabetes Tracker Log's Edge
Gamification mechanics significantly improve daily user retention compared to standard manual logging interfaces
Advanced data visualization tools provide deeper clinical insights for A1C management and trend analysis
Contenders
Specialized medication reminder engine with family caregiver alerts outperforms generic logging features
Drug-to-drug interaction checking provides a safety layer that standard diabetes trackers lack
OneTouch Reveal® app
★4.8 (158K)LifeScan, Inc.
📈A major contender backed by a medical device manufacturer, focusing on seamless hardware-to-app data synchronization.
Direct hardware ecosystem lock-in through proprietary blood glucose meter connectivity and data syncing
Clinical-grade reporting features designed specifically for sharing accurate data with healthcare providers
Libre by Abbott
★4.6 (105.5K)Abbott Labs
Dominates the CGM-specific niche, serving as a critical utility for users requiring real-time glucose monitoring.
Real-time glucose streaming capabilities eliminate the need for manual logging of blood sugar levels
Hardware-integrated alerts provide immediate notification of dangerous glucose fluctuations for patient safety
Peers
Aggressive price comparison engine for prescriptions creates a high-utility financial moat for patients
Massive user base and brand recognition as the primary tool for reducing healthcare costs
Kardia
★4.8 (210.9K)AliveCor, Inc.
⚡Adjacent chronic condition monitoring, focusing on cardiovascular health often comorbid with diabetes.
Medical-grade ECG analysis capabilities provide specialized diagnostic value beyond simple glucose tracking
Hardware-software synergy with portable ECG devices creates a distinct clinical diagnostic workflow
New Kids on the Block
Minimalist, single-purpose interface design reduces friction for elderly users tracking blood pressure
Rapid release cadence indicates a focus on quick feature deployment to capture niche users
The outtake for Glucose Buddy Diabetes Tracker
Strengths to defend, gaps to attack
Core Strengths
- 15-year market presence builds significant trust
- Direct hardware integration creates high switching costs
Critical Frictions
- 2.25★ Android rating vs 4.8★ iOS rating
- Persistent launch-time crashes on latest versions
- Unresponsive customer support for billing issues
Growth Levers
- Untapped B2B partnerships with health systems
- Expansion into comorbid condition tracking
Market Threats
- mySugr's 12-update cadence outpaces current development
- CGM-integrated apps eliminate manual logging needs
What are the next best moves?
Rebuild launch sequence because persistent crashes are the #1 churn driver → recover daily active user baseline
Sentiment analysis identifies launch-time crashes as the dominant complaint theme.
Trade-off: Pause the coaching-feature expansion — stability is a prerequisite for retention.
Audit paywall frequency because aggressive prompts are the #2 complaint theme → reduce negative review volume
User reviews explicitly cite paywalls as a barrier to core functionality.
Trade-off: Same-quarter capacity available — no major lever displaced.
A counter-intuitive read
The app's 15-year legacy is currently a liability, as the accumulated technical debt prevents the team from matching the rapid release cadence of newer, more stable competitors.
Feature Gaps vs Competitors
- Gamified logging experience (available in mySugr)
- Real-time CGM streaming (available in Libre by Abbott)
Key Takeaways
Glucose Buddy retains users through critical hardware integrations, but the app is failing to maintain basic stability, so the PM must prioritize technical hygiene over new feature growth to stop the churn.
Where Is It Heading?
Declining
The medical tracking market is consolidating around apps that offer real-time data streaming and high-frequency stability updates. Glucose Buddy remains exposed to churn because its current development cadence is insufficient to address the critical stability failures reported by users.
Persistent launch-time crashes prevent access to health data, which compounds the rating drag already visible on Android.
Aggressive subscription prompts block core interface access, accelerating churn pressure among the legacy user base.